SCHEMBL22097014

SCHEMBL22097014

c1ccc(-c2nc(-c3ccc4c(c3)c3ccccc3c3cc5c(cc43)oc3cc4c6ccccc6c6ccccc6c4cc35)nc3ccc4ccccc4c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 8/20 0.38
NPC1 O15118 5/20 0.38
RAB9A P51151 5/20 0.38
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
RECQL P46063 1/20 0.38
ABCG2 Q9UNQ0 2/20 0.38
CYP1A2 P05177 2/20 0.38
PAX8 Q06710 2/20 0.38
CYP1A1 P04798 1/20 0.38
FYN P06241 1/20 0.38
MAPK3 P27361 1/20 0.38
AHR P35869 1/20 0.38
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 6/20 0.38
HPGD P15428 4/20 0.38
WHR1 P49842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22097153 0.97 KMT2A (0.37) ATMMEN1KMT2AMAPTNPC1
SCHEMBL22249906 0.96 ABCG2 (0.40) ATMMEN1KMT2AMAPTNPC1
SCHEMBL22097141 0.94 MEN1 (0.35) ATMMEN1KMT2AMAPTNPC1
SCHEMBL22096957 0.89 MAPT (0.40) ATMMEN1KMT2AMAPTNPC1
SCHEMBL22097022 0.87 TDP1 (0.39) ATMMEN1KMT2AMAPTNPC1
SCHEMBL22249644 0.87 MAPT (0.35) MAPTNPC1RAB9ALMNASMN1; SMN2
SCHEMBL22096955 0.85 MEN1 (0.36) ATMMEN1KMT2AMAPTNPC1
SCHEMBL22249754 0.85 ALDH1A1 (0.39) ATMMEN1KMT2AMAPTNPC1
SCHEMBL22880130 0.84 ABCG2 (0.41) ATMMEN1KMT2AMAPTNPC1
SCHEMBL22879830 0.83 TDP1 (0.41) ATMMEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 ATM 3884/4885MEN1 1207/4885KMT2A 2500/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 ATM 3884/4885MEN1 1207/4885KMT2A 2500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.